Severe Primary Hypothyroidism Management

Initial Management

A TSH level of 336 mIU/L indicates severe primary hypothyroidism requiring immediate levothyroxine treatment to prevent progression to myxedema coma and other life-threatening complications 1
Initiate levothyroxine therapy immediately, as this extremely elevated TSH level (336 mIU/L) indicates severe hypothyroidism that requires prompt treatment 1
For patients without risk factors (under 70 years old, not frail, without cardiac disease), full replacement can be calculated using ideal body weight at approximately 1.6 mcg/kg/day 1
Measure free T4 along with TSH to confirm the diagnosis of primary hypothyroidism and rule out central hypothyroidism 1

Recheck TSH and free T4 levels 6-8 weeks after initiating therapy to assess response and adjust dosage as needed 1
Continue monitoring every 6-8 weeks while titrating hormone replacement to achieve a goal TSH within the reference range 1
Once adequately treated, repeat testing every 6-12 months or as indicated by a change in symptoms 1
Free T4 can be used to help interpret ongoing abnormal TSH levels during therapy, as TSH may take longer to normalize 1

For patients with myxedema (bradycardia, hypothermia, altered mental status), hospitalization is required 1
Inpatient endocrinology consultation can assist with IV levothyroxine dosing and supportive care 1
Myxedema coma is a life-threatening emergency requiring admission and a high level of care 1

Do not delay treatment with a TSH of 336, as this indicates severe hypothyroidism that requires immediate intervention 1